LENZ- Lenz Therapeutics, Inc.

Name: Lenz Therapeutics, Inc. Insider Trading Data
Creator: U.S. Securities and Exchange Commission
License: https://www.sec.gov/privacy#accessibility

Lenz Therapeutics, Inc. (LENZ) has 12 insiders with recent SEC Form 4 filings, including 15 buys and 0 sells. LENZ is classified in the Biotechnology industry within the Health Care sector.

Insider Ownership

Role	Insider	Shares	Value	30d
10%	Versant Venture Capital Vi, L.P.	764.3K	$7.69M	-
Other	Odrich Marc	84.2K	$847.1K	-
CEO	Schimmelpennink Evert B.	77.3K	$777.5K	-
Other	Olsson Shawn	14.0K	$140.8K	-
10%	Ra Capital Management, L.P.	13.5K	$135.8K	-

Activity

Buys and sells only

Transactions

9 filings · page 3

Date	Insider	Role	Type	Shares	Price	Value	Chg%	3M	12M
Jan 20, 2022	Samsara Biocapital, L.P.	10% Owner	Buy	97,670	$9.10	$888,677.20	+0.6%	-55.3%	-78.4%
Dec 15, 2021	Samsara Biocapital, L.P.	10% Owner	Buy	22,329	$10.19	$227,532.51	+0.3%	-28.7%	-72.5%
Nov 22, 2021	Samsara Biocapital, L.P.	10% Owner	Buy	201,685	$10.15	$2,047,102.75	+2.7%	-5.0%	-60.9%
Oct 15, 2021	Samsara Biocapital, L.P.	10% Owner	Buy	50,800	$13.14	$667,665.00	+0.2%	-21.6%	-76.1%
Oct 8, 2021	Samsara Biocapital, L.P.	10% Owner	Buy	145,496	$13.53	$1,968,972.99	+0.7%	-16.9%	-76.0%
Jun 29, 2021	Jerel Davis51	Director, 10% Owner	Buy	180,000	$17.00	$3,060,000.00	+11.8%	-39.1%	-89.9%
Jun 29, 2021	Versant Venture Capital Vi, L.P.64	10% Owner	Buy	180,000	$17.00	$3,060,000.00	+11.8%	-39.1%	-89.9%
Jun 29, 2021	Samsara Biocapital, L.P.	10% Owner	Buy	500,000	$17.00	$8,500,000.00	+7.2%	-39.1%	-89.9%
Jun 29, 2021	Shah Smital	Director	Buy	5,882	$17.00	$99,994.00	New	-39.1%	-89.9%

← PrevPage 3

Insider	Role	Shares	Value	Buys	Sells

Date	Ticker	Insider	Role	Type	Shares	Price	Value	Chg%	SEC